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CLINICAL SNIPPETS
Rich and Dangerous
Using data from the population-
based Northern Region Young 
Persons’ Malignant Disease 
Registry, from England, McNally 
and colleagues found that 
increased risk of malignant 
melanoma is linked to greater 
affluence, perhaps due to 
an association between 
increased UV exposure and 
lifestyle choices, such as a 
higher frequency of vacations. 
Furthermore, worse melanoma 
survival was associated with 
living in deprived areas, perhaps 
because of the smaller likelihood 
of seeking an early diagnosis 
or adhering to treatment plans. 
Thus, with regard to malignant 
melanoma in young people, 
socioeconomic factors are 
involved in both etiology and 
survival. See page 2703 
Immunosuppression 
Promotes Melanoma 
Growth
An expanding population of 
T-cell suppressors in cancer 
patients generates great 
immunosuppression. In a 
study of the mechanisms of 
such immunosuppression in 
melanoma, which regularly 
overcomes host antitumor 
immunity, Chung and colleagues 
demonstrated that the T-cell 
inhibitory receptor DC-HIL, 
which binds syndecan 4 and 
downregulates T-cell activation, 
was found on CD11b+Gr1+ 
myelomonocytic cells and 
promotes melanoma growth via 
IFN-γ and nitric oxide synthase. 
Blockade of DC-HIL function 
prevented both suppression of 
T-cell function and promotion 
of melanoma growth, 
suggesting that modulation 
of DC-HIL–expressing cells 
may be a powerful melanoma 
immunotherapy. See page 2784 
Rosacea News
Mast cells (MCs), which 
contribute to skin inflam-
mation, serve as a primary 
source of the antimicro-
bial peptide cathelicidin 
LL-37, which is a key 
initiator of the chronic 
inflammatory skin disease 
rosacea. Muto and col-
leagues demonstrated that cathelicidin LL-37 peptide activates skin MCs to release prote-
ases critical for rosacea inflammation. Mice deficient in MCs did not exhibit all rosacea-
like dermal events following intradermal cathelicidin LL-37 injection, suggesting that 
MCs are the missing link between rosacea flares and inflammation. Notably, the MC 
stabilizer cromolyn sodium suppressed rosacea inflammation development after cathe-
licidin LL-37 challenge, offering the possibility that MC stabilization may be a feasible 
target therapy for erythematotelangiectatic rosacea. See page 2728
Solar Exposure
Skin exposure to UV radiation is dangerous 
owing to the potential for DNA damage and 
subsequent development of skin malignan-
cies, but it is also beneficial, because UVB is 
the major source of vitamin D, which main-
tains bones and confers protection against 
diseases such as cancer. Whereas most stud-
ies have focused on laboratory UVB exposure, 
Petersen and colleagues studied real-life data 
from Spaniards and Danes on sun and ski holidays. Strong associations were identified 
between UVB exposure and DNA damage and between UVB exposure and vitamin D 
levels. In addition, a strong association was found between DNA damage and vitamin D 
synthesis, providing a basis for further studies aimed at analyzing the risks and benefits 
of solar exposure. See page 2806 
Taming of the T Cells
To study potential thera-
peutic strategies to ame-
liorate allergic contact 
dermatitis, Wang and 
colleagues examined the 
effects of the cyclodep-
sipeptide trichomide A, 
which was originally isolated from fermentation products of Trichothecium roseum. 
Trichomide A selectively inhibited proliferation of activated T cells, reduced proin-
flammatory cytokine production, arrested T cells in G0/G1, and suppressed activation 
of AKT and STAT3. In mice, trichomide A abrogated picryl chloride–induced contact 
hypersensitivity via the tyrosine phosphatase SHP2. This immunosuppressive activ-
ity highlights trichomide A as a potential treatment option for immune-related skin 
diseases. See page 2737 
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